Related Experiment Video
Updated: Aug 13, 2026
12:57
Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
[Conformationally altered proteins cause neurodegenerative diseases]
Martin Ingelsson1, Lars Nilsson, Hans Basun
1Geriatriska kliniken, AstraZeneca, Uppsala, Sweden. martin.ingelsson@pubcare.uu.se
Lakartidningen
|January 18, 2006
Summary
Protein aggregates in the brain are hallmarks of neurodegenerative diseases like Alzheimer's and Parkinson's. Understanding the molecular mechanisms offers hope for new treatments beyond symptom management.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Context:
- Neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, are characterized by the accumulation of misfolded protein aggregates in the brain.
- The discovery of genes linked to rare forms of these disorders has accelerated the understanding of underlying molecular mechanisms.
- Current treatments for neurodegenerative conditions primarily focus on managing symptoms, lacking disease-modifying capabilities.
Purpose:
- To elucidate the molecular mechanisms driving protein dysregulation in neurodegenerative disorders.
- To leverage genetic insights from rare disease forms to understand broader disease pathogenesis.
- To identify novel therapeutic targets for preventing or curing neurodegenerative diseases.
Summary:
- Brain protein aggregates are central to neurodegeneration, directly contributing to disease progression.
- Advances in understanding gene mutations causing rare neurodegenerative diseases are revealing key molecular pathways.
- New knowledge of these mechanisms opens avenues for developing disease-modifying therapies.
Impact:
- Potential for developing preventative strategies and curative treatments for devastating neurodegenerative disorders.
- Shifting therapeutic paradigms from symptomatic relief to addressing root molecular causes.
- Accelerating drug discovery and development for conditions like Alzheimer's and Parkinson's disease.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...